Jefferies Group LLC Glaukos Corp Put Options Transaction History

Jefferies Group LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	SELL	$34.86 - $63.77 $1.87 Million - $3.42 Million	-53,600 Reduced 71.18%	21,700 $985,000
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $1.87 Million - $3.42 Million	-53,600 Reduced 71.18%	21,700 $986,000
Q1 2022 Sep 21, 2023	BUY	$44.33 - $57.82 $1.49 Million - $1.94 Million	33,600 Added 80.58%	75,300 $4.35 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $1.49 Million - $1.94 Million	33,600 Added 80.58%	75,300 $4.35 Million
Q4 2021 Sep 21, 2023	BUY	$40.27 - $56.99 $805,400 - $1.14 Million	20,000 Added 92.17%	41,700 $1.85 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $1.68 Million - $2.38 Million	41,700 New	41,700 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $1.47 Million - $2.26 Million	-30,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $5.66 Million - $7.75 Million	-152,000 Reduced 83.52%	30,000 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $638,916 - $1.04 Million	-22,200 Reduced 10.87%	182,000 $6.99 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $5.01 Million - $13.8 Million	196,400 Added 2517.95%	204,200 $6.3 Million
Q4 2019 Feb 13, 2020	BUY	$54.18 - $65.64 $422,604 - $511,992	7,800 New	7,800 $425,000
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $842,450 - $1.34 Million	-16,600 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $1.74 Million - $2.27 Million	-33,400 Reduced 66.8%	16,600 $932,000
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $1.38 Million - $2.23 Million	50,000 New	50,000 $2.03 Million

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.